Poly (ε-caprolactone) incorporated bioactive glass nanoparticles and simvastatin nanocomposite nanofibers: Preparation, characterization and in vitro drug release for bone regeneration applications

Chemical Engineering Journal

Volumn 228, Issue , 2013, Pages 1057-1065

  Kouhi, Monireh ^a   Morshed, Mohammad ^a   Varshosaz, Jaleh ^b   Fathi, Mohammad Hossein ^a  

^a ISFAHAN UNIVERSITY OF TECHNOLOGY   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bioactive glass; Bioactivity; Drug release; Nanocomposite nanofiber; Poly caprolactone; Simvastatin

Indexed keywords

CAPROLACTONE; DRUG RELEASE; HYDROXYAPATITE LAYERS; NANOCOMPOSITE NANOFIBERS; NANOPARTICLE CONCENTRATIONS; PHOSPHATE BUFFER SALINES; SIMULATED BODY FLUIDS; SIMVASTATIN;

BIOACTIVE GLASS; BIOACTIVITY; BIODEGRADATION; DIFFERENTIAL SCANNING CALORIMETRY; MECHANICAL PROPERTIES; NANOCOMPOSITES; NANOPARTICLES; PHOSPHATE MINERALS; SCANNING ELECTRON MICROSCOPY; TENSILE STRENGTH;

NANOFIBERS;

EID: 84879466520     PISSN: 13858947     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cej.2013.05.091     Document Type: Article

References (42)

1. Zhang Z., Hu J., Ma P.X. Nanofiber-based delivery of bioactive agents and stem cells to bone sites. Adv. Drug Deliv. Rev. 2012, 65:1129-1141.
2. Abdal-hay A., Tijing L.D., Lim J.K. Characterization of the surface biocompatibility of an electrospun nylon 6/CaP nanofiber scaffold using osteoblasts. Chem. Eng. J. 2013, 215-216:57-64.
3. Pant H.R., Risal P., Park C.H., Tijing L.D., Jeong Y.J., Kim C.S. Core-shell structured electrospun biomimetic composite nanofibers of calcium lactate/nylon-6 for tissue engineering. Chem. Eng. J. 2013, 221:90-98.
4. Barakat N.A.M., Abadir M.F., Sheikh F.A., Kanjwal M.A., Park S.J., Kim H.Y. Polymeric nanofibers containing solid nanoparticles prepared by electrospinning and their applications. Chem. Eng. J. 2010, 156:487-495.
5. Bianco A., Federico E.D., Moscatelli I., Camaioni A., Armentano I., Campagnolo L., et al. Electrospun poly(ε-caprolactone)/Ca-deficient hydroxyapatite nanohybrids: microstructure, mechanical properties and cell response by murine embryonic stem cells. Mater. Sci. Eng. C 2009, 29:2063-2071.
6. Kim H.W., Lee H.H., Chun G.S. Bioactivity and osteoblast responses of novel biomedical nanocomposites of bioactive glass nanofiber filled poly (lactic acid). J. Biomed. Mater. Res. A 2008, 85:651-663.
7. Yang F., Wolke J.G.C., Jansen J.A. Biomimetic calcium phosphate coating on electrospun poly (e-caprolactone) scaffolds for bone tissue engineering. Chem. Eng. J. 2008, 137:154-161.
8. Charernsriwilaiwat N., Opanasopit P., Rojanarata T., Ngawhirunpat T. Lysozyme-loaded, electrospun chitosan-based nanofiber mats for wound healing. Int. J. Pharm. 2012, 427:379-384.
9. Huang Z.M., He C.L., Yang A., Zhang Y., Han X.J., Yin J., et al. Encapsulating drugs in biodegradable ultrafine fibers through co-axial electrospinning. J. Biomed. Mater. Res. A 2006, 77:169-179.
10. Zamani M., Morshed M., Varshosaz J., Jannesari M. Controlled release of metronidazole benzoate from poly e-caprolactone electrospun nanofibers for periodontal diseases. Eur. J. Pharm. Biopharm. 2010, 75:179-185.
11. Van E.L., Grondahl L., Chua K.N., Leong K.W., Nurcombe V., Cool S.M. Controlled release of heparin from poly(e-caprolactone) electrospun fibers. Biomaterials 2006, 27:2042-2050.
12. Ionescu L.C., Lee G.C., Sennett B.J., Burdick J.A., Mauck R.L. An anisotropic nanofiber/microsphere composite with controlled release of biomolecules for fibrous tissue engineering. Biomaterials 2010, 31:4113-4120.
13. Jose M.V., Thomas V., Johnson K.T., Dean D.R., Nyairo E. Aligned PLGA/HA nanofibrous nanocomposite scaffolds for bone tissue engineering. Acta Biomater. 2009, 5:305-315.
14. Boccaccini A.R., Maquet V. Bioresorbable and bioactive polymer/bioglass composites with tailored pore structure for tissue engineering applications. Compos. Sci. Technol. 2003, 63:2417-2429.
15. Schnieders J., Gbureck U., Thull R., Kissel T. Controlled release of gentamicin from calcium phosphate-poly(lactic acid-co-glycolic acid) composite bone cement. Biomaterials 2006, 27:4239-4249.
16. Hong Z., Reis R.L., Mano J.F. Preparation and in vitro characterization of scaffolds of poly(l-lactic acid) containing bioactive glass ceramic nanoparticles. Acta Biomater. 2008, 4:1297-1306.
17. Kim H.W., Knowles J.C., Kim H.E. Effect of biphasic calcium phosphates on drug release and biological and mechanical properties of poly(e-caprolactone) composite membranes. J. Biomed. Mater. Res. A 2004, 70:467-479.
18. Fabbri P., Bondioli F., Messori M., Bartoli C., Dinucci D., Chiellini F. Porous scaffolds of polycaprolactone reinforced with in situ generated hydroxyapatite for bone tissue engineering. J. Mater. Sci: Mater. Med. 2010, 21:343-351.
19. Kim H.W., Lee E.J., Jun I.K., Kim H.E., Knowles J.C. Degradation and drug release of phosphate glass/polycaprolactone biological composites for hard-tissue regeneration. J. Biomed. Mater. Res. B: Appl. Biomater. 2005, 75B:34-41.
20. Causa F., Netti P.A., Ambrosio L., Ciapetti G., Baldini N., Pagani S., et al. Poly-e caprolactone/hydroxyapatite composites for bone regeneration: in vitro characterization and human osteoblast response. J. Biomed. Mater. Res. A 2006, 76:151-162.
21. Li X., Shi J., Dong X., Zhang L., Zeng H. A mesoporous bioactive glass/polycaprolactone composite scaffold and its bioactivity behavior. J. Biomed. Mater. Res. A 2008, 84:84-91.
22. Misra S.K., Mohn D., Brunner T.J., Stark W.J., Philip S.E., Roy I., et al. Comparison of nanoscale and microscale bioactive glass on the properties of P(3HB)/bioglass composites. Biomaterials 2008, 29(12):1750-1761.
23. Singh N., Karambelkar A., Gu L., Lin K., Miller J.S., Chen C.S., et al. Bioresponsive mesoporous silica nanoparticles for triggered drug release. J. Am. Chem. Soc. 2011, 133:19582-19585.
24. Jones D.S., McCoy C.P., Andrews G.P. Physicochemical and drug diffusion analysis of rifampicin containing polyethylene glycol-poly (e-caprolactone) networks designed for medical device applications. Chem. Eng. J. 2011, 172:1088-1095.
25. Webber M.J., Matson J.B., Tamboli V.K., Stupp S.I. Controlled release of dexamethasone from peptide nanofiber gels to modulate inflammatory response. Biomaterials 2012, 33:6823-6832.
26. Chasman D.I., Posada D., Subrahmanyan L., Cook N.R., Jr Stanton V.P., Ridker P.M. Pharmacogenetic study of statin therapy and cholesterol reduction. J. Am. Med. Assoc. 2004, 291:2821-2827.
27. Rauch U., Osende J.I., Chesebro J.H., Fuster V., Vorchheimer D.A., Harris K., et al. Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins. Atherosclerosis 2000, 153:181-189.
28. Benoit D.S., Nuttelman C.R., Collins S.D., Anseth K.S. Synthesis and characterization of a fluvastatin-releasing hydrogel delivery system to modulate hMSC differentiation and function for bone regeneration. Biomaterials 2006, 27:6102-6110.
29. Adah F., Benghuzzi H., Tucci M., Russell G., England B. Cholesterol production inhibitor (statin) increased bone healing in surgically created femoral defect in an animal model. Biomed. Sci. Instrum. 2007, 43:95-103.
30. Piskin E., Isoglu A., Bolgen N., Vargel I., Griffiths S., Cavusoglu T., et al. In vivo performance of simvastatin-loaded electrospun spiral-wound polycaprolactone scaffolds in reconstruction of cranial bone defects in the rat model. J. Biomed. Mater. Res. A 2009, 90:1137-1151.
31. Thylin M.R., McConnell J.C., Schmid M.J., Reckling R.R., Ojha J., Bhattacharyya I., et al. Effects of simvastatin gels on murine calvarial bone. J. Periodontol. 2002, 73:1141-1148.
32. Fathi M.H., Doostmohammadi A. Bioactive glass nanopowder and bioglass coating for biocompatibility improvement of metallic implant. J. Mater. Process. Technol. 2009, 209:1385-1391.
33. Pitt C.G., Chasalow F.I., Hibionada Y.M., Klimas D.M., Schindler A. Aliphatic polyesters I. The degradation of poly(e-caprolactone) in vivo. J. Appl. Polym. Sci. 1981, 26:3779-3787.
34. Kokubo T., Takadama H. How useful is SBF in predicting in vivo bone bioactivity?. Biomaterials 2006, 27:2907-2915.
35. Fujihara K., Kotaki M., Ramakrishna S. Guided bone regeneration membrane made of polycaprolactone/calcium carbonate composite nano-fibers. Biomaterials 2005, 26:4139-4147.
36. Einstein A. Annu. Phys. 1906, 19:289-306.
37. Yang S., Leong K., Chua C. The design of scaffolds for use in tissue engineering. Part 1. Traditional factors. Tissue Eng. 2001, 7:679-689.
38. Miyajima M., Koshika A., Okada J., Kusai A., Ikeda M. Factors influencing the diffusion-controlled release of papaverine from poly(l-lactic acid) matrix. J. Control. Release 1998, 56:85-94.
39. Miyajima M., Koshika A., Okada J., Ikeda M. Mechanism of drug release from poly(l-lactic acid) matrix containing acidic or neutral drugs. J. Control. Release 1999, 60:199-209.
40. Hench L.L. Bioceramics: from concept to clinic. J. Am. Ceram. Soc. 1991, 74:1487-1510.
41. Vallet-Regí M., Romero A.M., Ragel C.V., LeGeros R.Z. XRD, SEM-EDS, and FTIR studies of in vitro growth of an apatite-like layer on sol-gel glasses. J. Biomed. Mater. Res. 1999, 44:416-421.
42. Rehman I., Knowles J.C., Bonfield W. Analysis of in vitro reaction layers formed on bioglass using thin-film X-ray diffraction and ATR-FTIR microspectroscopy. J. Biomed. Mater. Res. 1998, 41:162-166.